Back to results
US 12,497,359 B2Granted
Acrylamide derivatives
AssigneeNRG Therapeutics Ltd
InventorsNeil Miller, Richard Rutter, Jan Kulagowski, Richard Morphy, Tammy Ladduwahetty, John MacLean, Eric Talbot
Life of this patent
Estimating the term…
Abstract
The invention relates to compounds of formula (I) and related aspects.
Claims17
A compound of formula (I):
- wherein:
- R1a is H or methyl;
- R1b is H or fluoro;
- A is group (Ab), (Ac) or (Ad):
- wherein group (Ab) is:
- wherein:
- R4 is H, C1-4alkyl or C1-4alkylene(aryl);
- wherein said aryl is optionally substituted by 1, 2 or 3 substituents each independently selected from C1-4alkyl, C3-6cycloalkyl, C1-4alkoxy, C1-4haloalkyl, halo, CN, OH, NR4aR4b, SO2R4c and NHSO2R4c;
- R4a is selected from H and C1-4alkyl;
- R4b is selected from H, C1-4alkyl, C3-6cycloalkyl, C1-4alkoxy, C1-4haloalkyl, aryl and 4-7 membered heterocycloalkyl;
- R4c is selected from C1-4alkyl, C3-6cycloalkyl, C1-4alkoxy, C1-4haloalkyl, aryl and 4-7 membered heterocycloalkyl;
- R5 is H or C1-4alkyl;
- each R6 is independently C1-4alkyl or halo;
- n is 0, 1, 2 or 3;
- wherein group (Ac) is:
- wherein:
- R7 is C1-4alkyl, C1-4alkylene(OH) or C1-4alkyleneOC1-4alkyl;
- o is 1 or 2;
- wherein group (Ad) is:
- wherein:
- X is a bond, O or CH2;
- each R8 is independently halo, C1-4alkyl, C1-4alkoxy, OC1-4haloalkyl, OC1-4alkylene(C3-6cycloalkyl), OC1-4alkylene(4-7 membered heterocycloalkyl) or OH;
- wherein said heterocycloalkyl and cycloalkyl are optionally substituted by 1, 2 or 3 substituents independently selected from C1-4alkyl, C3-6cycloalkyl, C1-4alkoxy, C1-4haloalkyl, halo, CN, OH, NR8aR8b, SO2R8c and NHSO2R8c;
- R8a is selected from H and C1-4alkyl;
- R8b is selected from H, C1-4alkyl, C3-6cycloalkyl, C1-4alkoxy, C1-4haloalkyl, aryl and 4-7 membered heterocycloalkyl;
- R8c is selected from C1-4alkyl, C3-6cycloalkyl, C1-4alkoxy, C1-4haloalkyl, aryl and 4-7 membered heterocycloalkyl;
- each R9 is independently halo or C1-4alkyl;
- p is 0, 1 or 2;
- q is 0, 1, 2, 3 or 4;
- wherein B is:
- wherein:
- R10 is H, halo or C1-4alkyl;
- D, E and F are each independently C(R10);
- or one of D, E and F is N and the two remaining D, E and F groups are independently C(R10);
- and
- provided that the compound of formula (I) is not (E)-N-(3-fluoro-2-methylphenyl)-3-(1H-indazol-6-yl)acrylamide;
- or a pharmaceutically acceptable salt and/or solvate thereof.
34 more elements
Dependencies are inferred from the claim text.